세계의 임상 인텔리전스 시장 보고서(2025년)
Clinical Intelligence Global Market Report 2025
상품코드 : 1889336
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,505,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,403,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,301,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

임상 인텔리전스 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 79억 1,000만 달러로 평가되었고, 2025년에는 91억 1,000만 달러에 달할 것으로 추정되며, CAGR 15.2%로 성장이 전망되고 있습니다. 과거의 성장은 전자 건강 기록의 도입 확대, 데이터 중심의 의사결정에 대한 수요 증가, 헬스케어 데이터 증가, 헬스케어 IT 인프라의 확충, 환자 결과 개선에 대한 주목 증가에 기인하고 있습니다.

임상 인텔리전스 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 14.4%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측되며, 156억 1,000만 달러에 달할 전망입니다. 예측 기간에 있어서의 성장은 맞춤형 의료에 대한 주목 고조, 리얼타임 임상 인사이트 수요 증가, 원격 의료 및 원격 모니터링의 확대, 헬스 케어 디지털화에 대한 정부 지원 강화에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 인공지능(AI) 및 머신러닝의 진보, 자연언어처리의 혁신, 클라우드 기반 임상 인텔리전스 플랫폼 개발, 안전한 데이터 공유를 위한 블록체인 통합, 임상 분석에 있어서의 연구개발 증가 등이 있습니다.

전자 건강 기록(EHR)의 이용 확대는 과거 기간 동안 임상 인텔리전스 시장의 성장을 견인했습니다. 전자 건강 기록은 진단, 치료, 투약, 검사 결과 등의 상세한 건강 정보를 장기간 관리하는 환자의 의료 이력의 디지털 버전으로, 권한을 가진 의료 제공업체가 액세스할 수 있습니다. 전자 건강 기록의 성장은 의료 분야의 디지털 변환, 데이터 액세스 개선, 공급자 간의 협력 강화로 환자 결과 향상으로 추진되고 있습니다. 임상 인텔리전스는 대량의 환자 데이터를 분석하고 실용적인 지식을 만들어 전자 건강 기록을 보완하고 의료 제공업체가 데이터를 기반으로 의사 결정을 내리고 의료의 질과 효율성을 향상시키는 데 도움을 줍니다. 예를 들어, 2023년 6월에 영국 의회가 보고한 바에 의하면, 2023년 12월까지 NHS 트러스트의 90%가 전자 건강 기록을 도입해, 2025년 3월까지 완전 도입이 달성될 전망입니다. 따라서 전자 건강 기록의 도입 확대는 임상 인텔리전스 시장의 성장을 뒷받침했습니다.

임상 인텔리전스 시장의 주요 기업은 환자 평가를 향상시키고, 워크플로우를 효율화하며, 임상적 의사결정을 개선하기 위한 디지털 트리어지와 같은 AI 구동 솔루션을 개발하고 있습니다. 디지털 트리어지는 AI 탑재 툴을 사용하여 환자의 증상을 평가하고, 치료의 우선 순위를 정하며, 환자를 적절한 임상 경로로 효율적으로 유도합니다. 2025년 7월에는 미국에 본사를 둔 소프트웨어 서비스 회사 Expertity Inc.가 응급 의료용으로 설계된 최초의 임상 인텔리전스 솔루션인 Care Agent를 출시했습니다. 이 플랫폼은 AI를 활용하고 전자 의료 기록과 통합하여 클리닉 운영 및 환자 참여를 향상시킵니다. 추가 앱이 필요 없으며 안전한 웹 채팅 및 SMS 통신이 가능하여 개별화된 HIPAA 준수 경험을 제공합니다. 모듈형 기능에는 디지털 퇴원 통지, 검사 결과의 전달이 포함되며, 트리어지 평가 및 예약 리마인더 등의 기능 확장이 계획되어 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Clinical intelligence involves the use of advanced data analytics and information systems to collect, analyze, and interpret healthcare data from multiple sources including electronic health records, lab results, and patient monitoring systems. Its main goal is to provide actionable insights that help healthcare providers enhance patient outcomes, optimize clinical workflows, and make informed decisions in medical care.

The main components of clinical intelligence are software, hardware, and services. Software includes data analytics and decision-support platforms that collect, integrate, and analyze clinical data to improve patient outcomes, optimize workflows, and support evidence-based decision-making in healthcare. It leverages technologies such as artificial intelligence, machine learning, natural language processing, predictive analytics, business intelligence, and data mining, and is deployed through both on-premise and cloud-based models. Applications include predictive analytics, clinical decision support, population health management, performance management, reporting and dashboards, and risk management. End-users include hospitals, diagnostic centers, ambulatory care centers, research institutes, and pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The clinical intelligence market research report is one of a series of new reports from The Business Research Company that provides clinical intelligence market statistics, including clinical intelligence industry global market size, regional shares, competitors with a clinical intelligence market share, detailed clinical intelligence market segments, market trends and opportunities, and any further data you may need to thrive in the clinical intelligence industry. This clinical intelligence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical intelligence market size has grown rapidly in recent years. It will grow from $7.91 billion in 2024 to $9.11 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth during the historic period is attributed to the increasing adoption of electronic health records, rising demand for data-driven decision making, growing healthcare data volumes, expansion of healthcare IT infrastructure, and heightened focus on improving patient outcomes.

The clinical intelligence market size is expected to see rapid growth in the next few years. It will grow to $15.61 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing emphasis on personalized medicine, rising demand for real-time clinical insights, expansion of telehealth and remote monitoring, and growing government support for healthcare digitalization. Key trends in the forecast period include advancements in artificial intelligence and machine learning, innovations in natural language processing, development of cloud-based clinical intelligence platforms, integration of blockchain for secure data sharing, and increasing research and development in clinical analytics.

The rising use of electronic health records drove the growth of the clinical intelligence market during the historic period. Electronic health records are digital versions of patient medical histories maintained over time, containing detailed health information such as diagnoses, treatments, medications, and test results accessible to authorized healthcare providers. The growth of electronic health records is driven by digital transformation in healthcare, improving data accessibility and coordination among providers to enhance patient outcomes. Clinical intelligence complements electronic health records by analyzing large volumes of patient data to generate actionable insights, helping healthcare providers make data-driven decisions that improve care quality and efficiency. For instance, in June 2023, the UK Parliament reported that by December 2023, 90 percent of NHS trusts had implemented electronic health records, with full adoption achieved by March 2025. Therefore, increasing electronic health record adoption supported the growth of the clinical intelligence market.

Major companies in the clinical intelligence market are developing AI-driven solutions such as digital triage to enhance patient assessment, streamline workflows, and improve clinical decision-making. Digital triage uses AI-powered tools to assess patient symptoms, prioritize care, and direct patients to the appropriate clinical pathway efficiently. In July 2025, Experity Inc., a US-based software and services company, launched Care Agent, the first clinical intelligence solution designed for urgent care. The platform uses AI and integrates with electronic medical records to improve clinic operations and patient engagement. It enables secure web chat and SMS communication, providing a personalized, HIPAA-compliant experience without extra apps. Its modular features include digital discharge delivery, lab results communication, and planned enhancements such as triage assessments and appointment reminders.

In January 2023, Det Norske Veritas (DNV), a Norway-based risk management and assurance company, acquired Medicare Beneficiary Identifier (MBI) for an undisclosed sum. DNV aims to strengthen its presence in the digital health sector by leveraging MBI Healthcare Technologies' AI-driven data assurance solutions to improve patient safety, optimize care efficiency, and reduce errors in electronic health records. Medicare Beneficiary Identifier (MBI) is a UK-based company that delivers clinical intelligence through AI-backed technology and data quality expertise.

Major companies operating in the clinical intelligence market are Microsoft Corporation, Alphabet Inc. (Google LLC), Amazon Web Services (AWS), Optum (UnitedHealth Group), International Business Machines (IBM) Corporation, IQVIA, GE Healthcare Technologies, Inc., Koninklijke Philips N.V., Medtronic Plc, Medidata, AvoMD, Zebra Medical Vision, Teledoc Health, Health Catalyst, Tempus, PathAI, Biofourmis, Twin Health, BenevolentAI, Prometheus Biosciences, Abridge, Owkin, Insitro, Heidi Health, Pieces Technologies, Renalytix PLC, OpenEvidence, Bayesian Health, and SmarterDx.

North America was the largest region in the clinical intelligence market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical intelligence market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical intelligence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical intelligence market consists of revenues earned by entities by providing services such as data collection and integration, healthcare analytics, patient monitoring, and reporting and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical intelligence market also includes sales of clinical data analytics software, healthcare dashboards, reporting tools, and electronic health record (EHR) integration solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Intelligence Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical intelligence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for clinical intelligence ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical intelligence market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Clinical Intelligence Market Characteristics

3. Clinical Intelligence Market Trends And Strategies

4. Clinical Intelligence Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Clinical Intelligence Growth Analysis And Strategic Analysis Framework

6. Clinical Intelligence Market Segmentation

7. Clinical Intelligence Market Regional And Country Analysis

8. Asia-Pacific Clinical Intelligence Market

9. China Clinical Intelligence Market

10. India Clinical Intelligence Market

11. Japan Clinical Intelligence Market

12. Australia Clinical Intelligence Market

13. Indonesia Clinical Intelligence Market

14. South Korea Clinical Intelligence Market

15. Western Europe Clinical Intelligence Market

16. UK Clinical Intelligence Market

17. Germany Clinical Intelligence Market

18. France Clinical Intelligence Market

19. Italy Clinical Intelligence Market

20. Spain Clinical Intelligence Market

21. Eastern Europe Clinical Intelligence Market

22. Russia Clinical Intelligence Market

23. North America Clinical Intelligence Market

24. USA Clinical Intelligence Market

25. Canada Clinical Intelligence Market

26. South America Clinical Intelligence Market

27. Brazil Clinical Intelligence Market

28. Middle East Clinical Intelligence Market

29. Africa Clinical Intelligence Market

30. Clinical Intelligence Market Competitive Landscape And Company Profiles

31. Clinical Intelligence Market Other Major And Innovative Companies

32. Global Clinical Intelligence Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Intelligence Market

34. Recent Developments In The Clinical Intelligence Market

35. Clinical Intelligence Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기